Skip to content
Clinical Trials – home

Drug use disorder Diagnostics

8 / 13 trials open to patients6 countries

In short

Recognizing drug use disorder and seeking proper diagnosis can be a turning point in someone's life, opening the door to effective treatment and the possibility of recovery.

Key points

  • Substance use disorder is diagnosed through comprehensive clinical interviews, not just drug tests—doctors need to understand how use affects your whole life, not just whether substances are in your system.
  • The same diagnostic criteria can identify substance use disorder as mild, moderate, or severe, meaning the condition exists on a spectrum and doesn't always look like the dramatic portrayals in media.
  • You should seek diagnostic evaluation when substance use starts causing problems with relationships, work, school, or health, or when you find it difficult to cut down despite wanting to stop.
  • Young people who start using drugs early face higher risk because substance use affects how their developing brains finish growing, making early diagnosis and intervention particularly important.
  • Mental health conditions like depression or anxiety often occur alongside substance use disorder and need evaluation too, since both conditions affect the same brain areas and require integrated treatment.
  • Clinical trial participation requires additional diagnostic procedures beyond standard assessment, including specific documentation, baseline lab testing, and thorough screening for other health conditions.
  • Recovery is possible with treatment, though substance use disorder is considered a chronic, relapsing condition—meaning the brain changes can be lasting and people may face risk of returning to use even after years of abstinence.
  • Not everyone who uses drugs becomes addicted, but it's impossible to predict who will develop substance use disorder and who won't, making any drug misuse potentially risky regardless of individual characteristics.

Introduction: Who Should Seek Diagnostic Evaluation

If you or someone close to you is struggling with patterns of substance use that seem to be causing problems, it may be time to consider a diagnostic evaluation. Drug use disorder, also known as substance use disorder, is a mental health condition where a person experiences a problematic pattern of substance use that affects their health, relationships, and daily functioning. This isn't about occasional experimentation or a single mistake—it's about patterns that begin to take control of someone's life.

People should consider seeking diagnostics when they notice certain warning signs in themselves or loved ones. These include using substances in larger amounts or for longer periods than intended, experiencing strong cravings that are hard to resist, or finding it difficult to cut down despite wanting to stop. When substance use starts interfering with responsibilities at work, school, or home, or when relationships suffer because of it, these are clear signals that professional evaluation is needed.

It's particularly important to seek help when someone continues using substances despite knowing they're causing physical or psychological harm. If a person needs increasing amounts of a substance to feel the same effect, or experiences uncomfortable symptoms when they stop using, these are signs that the body and brain have been affected in deeper ways. Anyone noticing these patterns should reach out to a healthcare provider for assessment.

Certain groups face higher risks and may benefit from earlier evaluation. People with untreated mental health conditions like depression, anxiety, or attention deficit hyperactivity disorder are more vulnerable to developing substance use problems. Those who experienced trouble at home during childhood, difficulties at school or work, or who spend time with others who use drugs may also be at increased risk. Young people who start using substances early face particular danger, as drug use during development can permanently affect how the brain finishes growing and increase the likelihood of addiction in adulthood.

Diagnostic Methods for Identifying Drug Use Disorder

Diagnosing drug use disorder requires a thorough and careful evaluation by trained healthcare professionals. The process typically involves assessment by specialists such as a psychiatrist, psychologist, or licensed alcohol and drug counselor who can properly evaluate the full scope of someone's substance use and its impact on their life.

Clinical Interview and Assessment

The cornerstone of diagnosis is a comprehensive clinical interview. During this evaluation, the healthcare provider will ask detailed questions about substance use patterns, including what substances are being used, how often, in what amounts, and for how long. They will explore the circumstances around use—whether someone uses alone or with others, what triggers the urge to use, and what effects the person experiences. The provider will also inquire about previous attempts to reduce or stop using substances and what happened during those attempts.

Healthcare professionals use specific diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association. This manual provides standardized criteria that help doctors determine whether someone has a substance use disorder and how severe it is. The severity can range from mild to moderate to severe, based on how many symptoms are present.

According to these criteria, doctors look for a cluster of signs. These include taking substances in larger amounts than intended, having strong cravings, spending excessive time obtaining or using substances, or recovering from their effects. They assess whether substance use has caused problems at work, school, or home, and whether the person has given up important activities because of substance use. The evaluation also considers whether someone continues using despite knowing it's causing physical or mental health problems, whether they've developed tolerance (needing more to get the same effect), and whether they experience withdrawal symptoms when stopping.

Laboratory Testing

Blood, urine, or other laboratory tests play an important supporting role in the diagnostic process. While these tests can detect the presence of drugs in the body and assess drug use, they are not used alone to diagnose addiction. Instead, they serve as tools to monitor treatment progress and recovery over time. Lab tests can confirm which substances someone has been using and help healthcare providers understand the physical impact of substance use on the body.

These tests can measure drug levels in blood or urine, showing recent use of specific substances. They may also check for health complications related to substance use, such as liver damage, kidney problems, or infections. The results help paint a fuller picture when combined with the clinical interview and other assessment findings.

Assessment of Physical and Psychological Symptoms

Doctors will carefully evaluate symptoms that occur when substances are in the body (intoxication) and symptoms that appear when substances leave the body (withdrawal). Intoxication symptoms vary depending on the substance but might include changes in alertness, mood, judgment, or physical coordination. These effects are immediate and short-term, but they reveal how the substance affects someone's functioning.

Withdrawal symptoms are equally important diagnostic indicators. When someone who has been using substances regularly suddenly stops or reduces use, they may experience uncomfortable physical and psychological symptoms. These can include nausea, vomiting, diarrhea, sweating, difficulty sleeping, muscle cramping, and mood changes. The presence and severity of withdrawal symptoms help doctors understand how dependent the body has become on the substance.

Evaluation of Mental Health and Co-occurring Conditions

A thorough diagnostic evaluation must also assess mental health conditions that might exist alongside substance use disorder. Many people with substance use problems also struggle with depression, anxiety, or other mental health conditions. These conditions affect the same parts of the brain that substance use affects, and people sometimes use drugs or alcohol to try to feel better when they're struggling emotionally. Identifying these co-occurring conditions is crucial because both need treatment for the best recovery outcomes.

Distinguishing from Other Conditions

Healthcare providers work carefully to distinguish substance use disorder from other medical or psychiatric conditions that might cause similar symptoms. Some physical illnesses, neurological conditions, or medication side effects can produce behavioral changes that might be mistaken for substance-related problems. Similarly, mental health conditions can sometimes present with symptoms that overlap with substance use patterns. The diagnostic process involves ruling out these other possibilities through careful questioning, physical examination, and sometimes additional medical tests.

The evaluation also considers the context of someone's life. Doctors will ask about family history, since genetics play a role in vulnerability to substance use disorders. They'll inquire about social environment, including home life, work or school situations, and peer relationships. Understanding these factors helps determine risk levels and shapes treatment planning.

Diagnostics for Clinical Trial Qualification

When people with substance use disorder consider participating in clinical trials testing new treatments, they typically undergo additional diagnostic evaluations beyond standard clinical assessment. Clinical trials use specific criteria to determine who can enroll, and these criteria ensure that the research produces reliable results while keeping participants safe.

For qualification into clinical trials, researchers typically require documentation of a formal diagnosis using the standardized criteria from the Diagnostic and Statistical Manual of Mental Disorders. Potential participants must meet the specific definition of substance use disorder for the trial, often including a minimum severity level. Some trials may focus only on severe cases, while others might include people across the spectrum from mild to severe.

Laboratory testing plays a more prominent role in clinical trial screening than in general diagnosis. Researchers often require baseline drug testing to confirm recent substance use and establish what substances someone has been using. These tests help ensure that participants actually have the condition being studied and provide a starting point for measuring improvement during the trial. Blood tests may also check liver and kidney function, as some trial medications could affect these organs, and researchers need to know participants can safely process the treatments being tested.

Clinical trials usually require detailed documentation of substance use history. This includes information about when use began, patterns of use over time, previous treatment attempts, and any periods of abstinence. Researchers want to understand the full picture of someone's experience with substances to ensure they meet study criteria and to analyze how different histories might affect treatment response.

Mental health screening is particularly thorough for clinical trial enrollment. Researchers assess for co-occurring mental health conditions that might affect participation or safety. Some trials may exclude people with certain psychiatric conditions, while others specifically study treatments for people with both substance use disorder and mental health conditions. The screening process ensures participants are placed in appropriate trials that can safely accommodate their full health profile.

Physical health examinations and medical history reviews are standard parts of clinical trial qualification. Researchers need to know about any other medical conditions, medications someone is taking, and overall health status. This information helps determine whether someone can safely participate and whether other health factors might interfere with the trial results. Some trials have specific inclusion or exclusion criteria based on physical health conditions.

Clinical trials may also require assessment of social support systems and living situations. Since many trials involve regular visits, medication adherence, and follow-up appointments, researchers need to know that participants can reliably attend and follow study protocols. Some trials provide support services or require participants to have stable housing or transportation arrangements to ensure they can complete the study.

Prognosis and Survival Rate

Prognosis

The outlook for people with drug use disorder varies significantly based on individual circumstances, but there is reason for hope. Substance use disorder is considered a treatable mental health condition, and recovery is possible for everyone who seeks help. However, because repeated drug use changes the brain in lasting ways, drug use disorder is considered a chronic, relapsing disease. This means that people in recovery remain at risk for returning to drug use, even after years of not taking substances.

Several factors affect someone's chances for positive outcomes. Not everyone who uses drugs becomes addicted—individual reactions differ based on biology, genetics, mental health status, and environmental factors. Some people may become addicted quickly, while others use substances without developing disorder. The severity of the condition also matters, as substance use disorder ranges from mild to moderate to severe, with more severe cases typically requiring more intensive treatment approaches.

The age at which someone begins using substances significantly influences their prognosis. When young people use drugs, it affects how their bodies and brains finish developing, which increases the chances of becoming addicted as adults. People with untreated mental health problems alongside substance use disorder face additional challenges, as both conditions need treatment for the best outcomes. The presence of strong social support, stable housing, employment or education, and access to quality treatment all improve someone's chances of successful recovery.

With effective treatment, including therapy, medication when appropriate, and ongoing support, many people successfully manage substance use disorder and maintain long-term recovery. The journey may involve setbacks, but each attempt at recovery builds knowledge and skills. Treatment helps people regain control over substance use and rebuild their lives, even when the underlying vulnerability to addiction remains.

Survival rate

Drug use disorder can be life-threatening, and mortality rates depend heavily on the substances involved and individual circumstances. The condition significantly impacts life expectancy and can be fatal through multiple mechanisms. Overdose represents one of the most serious and immediate risks—tens of thousands of people die from drug overdoses in the United States each year, with opioid overdoses being particularly common. Overdose can happen even from using substances just once, not only in people with established substance use disorder.

Beyond overdose, drug use disorder increases risk for numerous other life-threatening conditions that affect long-term survival. These include heart disease, hepatitis, HIV and other sexually transmitted infections, and various complications related to the method of drug use or the substances themselves. Substance use can also increase risk for accidents, injuries, and violence, all of which affect mortality rates.

The good news is that treatment dramatically improves survival outcomes. People who engage with treatment services and achieve periods of sustained recovery have significantly better health and longer life expectancy compared to those who continue active substance use without treatment. Early intervention, continuous care, and long-term follow-up all contribute to better survival rates and quality of life for people managing substance use disorder.

Did you know?

  1. Your brain and body can react completely differently to substances than someone else's—some people feel so uncomfortable the first time they try a drug that they never want to use it again, while others immediately crave more, making addiction risk highly individual.
  2. The same diagnostic manual that doctors use to identify substance use disorder (the DSM-5) can classify the condition as mild, moderate, or severe based on how many symptoms you have, meaning not all substance use disorders look the same or require identical treatment approaches.
  3. Laboratory drug tests, despite being commonly used, cannot actually diagnose addiction by themselves—they only show whether substances are present in your body, and a proper diagnosis requires assessing whether use is causing problems in your life through detailed clinical evaluation.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Drug use disorder

Recruiting trials first

See all 13 trials →
Quick filters

13 clinical trials in this condition

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Cessation Therapeutics Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:NALDEMEDINE
  • Sponsor:Aalborg University Hospital
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Buprenorphine
  • Sponsor:Linkopings Universitet
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Buprenorphine
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Helse Bergen HF
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Baclofen
  • Sponsor:Stichting Radboud universitair medisch centrum
See all 13 trials →filters applied: condition = Drug use disorder

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).